OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,163 | +19.1% | 17,230 | +1.8% | 0.00% | – |
| Q2 2023 | $55,530 | -36.2% | 16,930 | -22.1% | 0.00% | – |
| Q1 2021 | $87,000 | +74.0% | 21,739 | 0.0% | 0.00% | – |
| Q4 2020 | $50,000 | -60.0% | 21,739 | 0.0% | 0.00% | – |
| Q3 2020 | $125,000 | -21.9% | 21,739 | 0.0% | 0.00% | – |
| Q2 2020 | $160,000 | – | 21,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |